The final countdown to ASH 2024 is on! This year's meeting brings together the brightest minds in hematology to explore innovations that are transforming patient care and improving patient outcomes. Our team will be there, sharing insights and solutions to break down access barriers and bring life-changing medicines to patients in need. Stop by our booth or connect with us to learn more. We look forward to seeing you in San Diego!
Precision AQ’s Post
More Relevant Posts
-
Want to hear about FeNO from the experts who use it? In our new edition of FeNO Stories, we hear from Professor Vibeke Backer in an exclusive Q&A, on how she uses FeNO testing in the daily clinic. Read here: https://lnkd.in/es4r9quw
Maximising the benefit of FeNO testing for airway inflammation in the daily clinic - United States
niox.com
-
Think Phase 1 clinical trials aren't worth your time? 🤔 Think again. Join our webinar on Dec 9th to find out why these trials might just be your best option. Dr. Jason Sager will explain. #CancerAwareness #ClinicalTrials https://lnkd.in/g4kyXZRA
Debunking 3 Common Cancer Myths: An Expert Conversation with Dr. Jason Sager
sagelyhealth.com
-
Want to hear about FeNO from the experts who use it? In our new edition of FeNO Stories, we hear from Professor Vibeke Backer in an exclusive Q&A, on how she uses FeNO testing in the daily clinic. Read here: https://lnkd.in/es4r9quw
FeNO Story: Maximising the benefit of FeNO testing for airway inflammation in the daily clinic
niox.com
-
Mark your calendar for this exciting new session at #OSNNYandRetina 2024!
LIVE from New York, it’s Saturday Night CME 🍎🌃🗽 Join us Saturday evening during OSN New York for an exclusive reception. Enjoy a drink and light snacks as we explore how second-generation anti-VEGF therapies and sustained-release steroids are taking center stage in retinal disease treatment. With dynamic Curbside Consults, you’ll get the insider scoop on integrating these innovative therapies into real-world practice to make smarter management decisions based on the latest clinical data. Don’t miss your chance to mingle, learn, and elevate your expertise! Moderated by Rishi Singh with W. Lloyd Clark, Manjot Gill MD, MS, FASRS, FRCS(C) Guest Panelist: Ferhina S. Ali, MD MPH, Jorge Fortun & Katherine Talcott Click here for more info & to RSVP: https://lnkd.in/eGhvCk3r This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. Robert Esgro Jenna Gentile Bridget O’Brien Simon Cooper Sandra Hannaford Tyler Rosati
-
-
Mark your calendars for the free ISPOR webinar on Wednesday 4/12 to gain valuable insights on clinical outcomes for decision making in rare diseases with the example of Duchenne muscular dystrophy (DMD). Use the link below to sign up
Italfarmaco is proud to sponsor an ISPOR Educational Webinar on December 4th 2024, titled: “Leveraging the Value of Clinical Outcomes in DMD for Decision Making”. The webinar will be moderated by Dr. Francois Meyer and will include talks from three highly distinguished experts in DMD: Prof. Valeria Sansone; Conny Pelicaen and Dr. Paolo Bettica. Don’t miss the opportunity to gain insights into DMD, from understanding disease progression to navigating key disease milestones, as well as the complexities of clinical trial design in this therapeutic area. Discover the importance of collaboration among patient advocates, clinicians, and industry to improve patient access to innovative treatments. Italfarmaco’s rare diseases mission is to bring new opportunities to the rare diseases community, with innovation, quality, knowledge and motivation that can help more people suffering from rare diseases, than ever before. For additional information: https://lnkd.in/epmWhwBm
-
-
Learn more about what the Cystic Fibrosis Foundation and others are doing to support clinical trial progress today on #ClinicalTrialsDay.
On Clinical Trials Day, we celebrate cystic fibrosis research teams and study participants who pave the way for new CF treatments. Clinical trials have led to incredible breakthroughs in the treatment of CF and make living with CF better for thousands of people. Thank you for making a difference!
-
-
In this episode of “Answers From the Lab,” Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guest Donald Thomas, M.D., a rheumatologist and lupus researcher. They discuss how Mayo Clinic Laboratories’ suite of innovative lupus testing, offered in collaboration with Progentec Diagnostics, Inc., is enhancing the care and quality of life for patients affected by systemic lupus erythematosus. https://bit.ly/4e9aXt0
-
Clinical trial participation has been proven repeatedly to improve patient outcomes by providing access to new therapies and more frequent monitoring. The World Pancreatic Cancer Coalition recommends that every person be given a chance to enrol in a clinical trial. Numerous success stories underscore the potential benefits of clinical trials; however, Canadian participation remains alarmingly low. According to the University of Windsor, only about 7% of Canadians with cancer participate in clinical trials, and this figure drops by almost half in smaller provinces and rural areas (Sharma et al., 2022). In contrast, major centers like Princess Margaret Hospital in Toronto achieve around 21% engagement. This low engagement hinders Canada’s ability to advance cancer treatment and improve its stagnant survival rates.
Planning ahead for Clinical Trials
heathercutler.ca
-
Clinical Program Manager @ inHealth Lifestyle Therapeutics | National Board Certified Health and Wellness Coach
Discover the Power of Interdisciplinary Care with seca mBCA North America and inHealth Lifestyle Therapeutics! This webinar on March 29th will show you how to fill the void in traditional obesity care through our collaborative efforts. Get insights from the SECA and inHealth Lifestyle Therapeutics experts!
🔥 Last Chance to Join! 🔥 🔍 Discover the Power of Interdisciplinary Care with seca mBCA North America and inHealth Lifestyle Therapeutics! Our webinar on March 29th will show you how to fill the void in traditional obesity care through our collaborative efforts. Get insights from the experts! Dr. Nina Crowley, PhD, RDN, LD, Dr. Michelle Kulovitz Alencar, PhD, NBC-HWC, and Andrea Wilson will be building a stronger patient support network. 🎟️ Seats are going fast! Register now so you don’t miss out on this opportunity to advance your patient care approach. Let's make a difference together! REIGSTER TODAY: https://lnkd.in/etHwAWkD
-
